IL1F10 and inflammatory bowel disease: Up-regulated IL-38 expression is detected in inflamed skin (18), the active inflamed tissues of inflammatory bowel disease (24), rheumatoid arthritis (25), psoriatic skin (23), and in drug-induced liver injury patients (26), suggesting the induction of an anti-inflammatory role of IL-38 in response to focal inflammation.